In metastatic prostate cancer, docetaxel-based chemotherapy, which stabilizes microtubules, remains a first-line treatment
Authors Samuel Gratzl, PhD, Patricia J Rodriguez, PhD, MPH, Brianna M Goodwin Cartwright, MS Charlotte Baker, DrPH, MPH, CPH , Nicholas L Stucky, MD, PhD Accessed in December 2024 via [8] University of California- San Diego
The Medicare GLP-1 Bridge launched July 1, 2026 , giving eligible Part D beneficiaries Foundayo for $50/month
The antioxidant EPC-K1 ameliorates brain injury by inhibiting lipid peroxidation in a rat model of transient focal cerebral ischaemia
Most side effects are gastrointestinal and dose-dependent: nausea, reflux, constipation, or feeling full earlier than usual